Stay updated on SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial
Sign up to get notified when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.

Latest updates to the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.0.2 is now shown, replacing v3.0.1. The 'Back to Top' link was removed, a minor UI change; no other substantive content changes were detected.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has been updated to include new drug information, facility names, and locations, while removing outdated genetic resources and certain drug classifications. Notably, the addition of specific drugs and their details enhances the core content significantly.SummaryDifference5%
- Check25 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.3%
- Check32 days agoChange DetectedThe web page has updated its version to v2.16.12 and removed previous dates, indicating a revision in content. The new dates added suggest a potential update in scheduling or events.SummaryDifference0.4%
- Check39 days agoChange DetectedThe webpage has updated its status from 'Recruiting' to 'Active, not recruiting', indicating a change in the availability of participation in the related study. Additionally, several contact details for principal investigators have been removed, which may affect how users can reach out for information.SummaryDifference15%
Stay in the know with updates to SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-5613 Combo with Chemo in Relapsed Leukemia Clinical Trial page.